Immuron (IMRN) Current Assets (2016 - 2025)
Immuron (IMRN) recorded quarterly Current Assets of $99780.0 in Q3 2025, down 98.44% quarter-over-quarter from $6.4 million in Q2 2025, and down 32.24% on a YoY basis from $147263.4 in Q3 2024.
Immuron (IMRN) Current Assets (2016 - 2025) Analysis & Trends
Immuron's Current Assets history runs 10 years deep, the most recent figure standing at $99780.0 for Q3 2025.
- In Q3 2025, Current Assets fell 32.24% year-over-year to $99780.0; the TTM figure through Sep 2025 stood at $99780.0 (down 32.24% YoY), while the FY2025 annual figure was $99780.0, down 32.24% from the prior year.
- Current Assets was $99780.0 for Q3 2025 at Immuron, down from $6.4 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $19.8 million in Q2 2021 to a low of $99780.0 in Q3 2025.
- Historically, Current Assets has averaged $9.9 million across 5 years, with a median of $11.5 million in 2023.
- The sharpest annual moves came in 2021 and 2023: Current Assets jumped 6808.95% in 2021, then plunged 99.21% in 2023.
- A 5-year view of Current Assets shows it stood at $18.9 million in 2021, then decreased by 17.5% to $15.6 million in 2022, then sank by 99.21% to $123340.8 in 2023, then jumped by 6132.72% to $7.7 million in 2024, then slumped by 98.7% to $99780.0 in 2025.
- The last three Current Assets figures came in at $99780.0 (Q3 2025), $6.4 million (Q2 2025), and $7.7 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 3.59 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 600.85 Mn |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - | 99,780.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 99,780.03 |
| Jun 30, 2025 | 6.41 Mn |
| Dec 31, 2024 | 7.69 Mn |
| Sep 9, 2024 | 147,263.37 |
| Jun 30, 2024 | 9.71 Mn |
| Dec 31, 2023 | 123,340.82 |
| Sep 28, 2023 | 13.38 Mn |
| Aug 30, 2023 | 204,093.37 |
| Jun 30, 2023 | 13.64 Mn |
| Dec 31, 2022 | 15.55 Mn |
| Aug 31, 2022 | 16.46 Mn |
| Jun 30, 2022 | 16.96 Mn |
| Dec 31, 2021 | 18.85 Mn |
| Jun 30, 2021 | 19.83 Mn |
| Dec 31, 2020 | 272,856.21 |
| Sep 1, 2020 | 4.41 Mn |
| Jun 30, 2020 | 2.89 Mn |
| Dec 31, 2019 | 44,090.41 |
| Jun 30, 2019 | 4.68 Mn |
| Dec 31, 2018 | 7.05 Mn |